FLOW AND IMAGE CYTOMETRIC STUDY OF PANCREATIC NEUROENDOCRINE TUMORS - FREQUENT DNA ANEUPLOIDY AND AN ASSOCIATION WITH THE CLINICAL OUTCOME

被引:10
作者
ALANEN, KA
FALKMER, UG
KLEMI, PJ
JOENSUU, H
FALKMER, S
机构
[1] KAROLINSKA INST & HOSP,DEPT TUMOUR PATHOL,STOCKHOLM,SWEDEN
[2] UNIV TURKU,CENT HOSP,SF-20520 TURKU 52,FINLAND
[3] UNIV TURKU,DEPT ONCOL & RADIOTHERAPY,SF-20500 TURKU 50,FINLAND
关键词
ISLET-CELL NEOPLASMS; INSULINOMA; GASTRINOMA; GLUCAGONOMA; DNA INDEX;
D O I
10.1007/BF01607044
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Eighteen pancreatic neuroendocrine (NE) tumours were analysed for nuclear DNA content by image cytometry (ICM) and flow cytometry (FCM). The DNA indices (DIs) obtained by ICM were somewhat higher than those obtained by FCM, but a major disagreement was present only in 1 case. Thirteen patients had been followed up at least for 6 years after the diagnosis or until death. At 6 years of follow-up all 4 patients with a tumour with a DI greater-than-or-equal-to 1.8 by ICM had died from their NE tumour or had metastatic disease, whereas all 9 patients with a smaller DI had no evidence of the disease (P = 0.001). The DIs calculated from the FCM data also correlated well with the final outcome (P = 0.01). A high incidence of DNA aneuploidy was found,by both methods in histologically and clinically benign NE tumours; 12 (67%) were DNA aneuploid by FCM and 16 (89%) by ICM. It is concluded that pancreatic NE tumours are frequently DNA aneuploid, and both cytometric DNA methods give prognostic information in these tumours. The presence of DNA aneuploidy should not be considered as a sign of malignant behaviour in pancreatic NE tumours, whereas a large DI is associated with poor prognosis.
引用
收藏
页码:121 / 125
页数:5
相关论文
共 21 条
[1]   AUTOLYSIS IS A POTENTIAL SOURCE OF FALSE ANEUPLOID PEAKS IN FLOW CYTOMETRIC DNA HISTOGRAMS [J].
ALANEN, KA ;
JOENSUU, H ;
KLEMI, PJ .
CYTOMETRY, 1989, 10 (04) :417-425
[2]   DNA PLOIDY IN PANCREATIC NEUROENDOCRINE TUMORS [J].
ALANEN, KA ;
JOENSUU, H ;
KLEMI, PJ ;
MARIN, S ;
ALAVAIKKO, M ;
NEVALAINEN, TJ .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1990, 93 (06) :784-788
[3]  
ASKENSTEN U, 1990, Archiv fuer Geschwulstforschung, V60, P209
[4]   INTRATUMORAL VARIATIONS IN DNA DISTRIBUTION PATTERNS IN MAMMARY ADENOCARCINOMAS [J].
ASKENSTEN, UG ;
VONROSEN, AK ;
NILSSON, RS ;
AUER, GU .
CYTOMETRY, 1989, 10 (03) :326-333
[5]   CYTOPHOTOMETRY [J].
AUER, G ;
ASKENSTEN, U ;
AHRENS, O .
HUMAN PATHOLOGY, 1989, 20 (06) :518-527
[6]  
Bohm N, 1975, Curr Top Pathol, V60, P151
[7]   SYNAPTOPHYSIN - A NEW MARKER FOR PANCREATIC NEUROENDOCRINE TUMORS [J].
CHEJFEC, G ;
FALKMER, S ;
GRIMELIUS, L ;
JACOBSSON, B ;
RODENSJO, M ;
WIEDENMANN, B ;
FRANKE, WW ;
LEE, I ;
GOULD, VE .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1987, 11 (04) :241-247
[8]   NUCLEAR-DNA CONTENT IN 27 PANCREATIC ENDOCRINE TUMORS - CORRELATION WITH MALIGNANCY, SURVIVAL AND EXPRESSION OF GLYCOPROTEIN HORMONE ALPHA-CHAIN [J].
DONOW, C ;
BAISCH, H ;
HEITZ, PU ;
KLOPPEL, G .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1991, 419 (06) :463-468
[9]  
FALLENIUS AG, 1988, CANCER, V62, P331, DOI 10.1002/1097-0142(19880715)62:2<331::AID-CNCR2820620218>3.0.CO
[10]  
2-8